Medtronic updates SPYRAL HTN-ON MED study timeline; interim analysis in late October

Medtronic plc

Prespecified interim look at ON MED study data by independent monitoring board scheduled for late October.
If primary endpoint achieves statistical significance, trial investigators can present at TCT in early November.
ON MED study will not be on TCT late-breaking clinical trial agenda due to late October data timing.
Company working with CRF to ensure data is featured at TCT if endpoint met; enrollment will cease if significant.
If primary endpoint not significant at interim, enrollment will continue to full predefined sample size.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.